Five Elms Capital
4801 Main St Ste 700, Kansas City, MO, 64112, United States
Overview
Five Elms Capital is a global growth equity firm that invests in fast-growing B2B software businesses that users love. Five Elms provides capital and resources to help companies accelerate growth and further cement their role as industry leaders. Since firm inception in 2007, Five Elms has focused exclusively on software investing, building an unmatched network and deep domain expertise. Today, with over $2.4 billion in assets under management and a global team of over 70 investment professionals, Five Elms has invested in more than 65 software platforms globally.
- Total investments
- 51
- Lead investments
- 49
- Investments · 12mo
- 4
- Active investors
- 7
Sector focus
- Financial Services
- Venture Capital
Investment portfolio
- Trybe
Led · Series A · Jan 2026
Founded in 2020, Trybe has built a configurable SaaS operating system that spans online bookings, scheduling, staff management, memberships, POS, guest communications, reporting and payments for spa, wellness and leisure operators. The platform currently supports more than 325 properties across 33 countries and has processed over 4.5 million transactions representing more than $1.1 billion in revenue volume. Key usage metrics show that 50 % of bookings occur outside office hours and 74 % are captured as part of broader spa packages, underscoring its revenue-generation impact. Trybe is now layering in AI-assisted scheduling, forecasting and personalization to further optimize yield and guest experience. Future product plans also include expanded card-present capabilities, enhanced settlement flexibility and deeper reporting, membership and package functionality. With strong uptake from single-site spas to large multi-site resort groups, the company is preparing for accelerated geographic expansion across North America, Europe and Asia-Pacific. The recently secured Series A financing will help scale sales, marketing and customer success to meet this growing demand.
- Ritten
Led · Series B · Dec 2025
Founded in 2020, Philadelphia-based Ritten unifies electronic health records, customer relationship management, and revenue cycle management into a single, AI-powered system of record tailored to behavioral health and addiction treatment organizations. The platform streamlines referrals, admissions, scheduling, charting, compliance, and billing for both outpatient and residential settings, aiming to reduce clinician burnout and increase operational efficiency. Ritten’s technology serves a wide range of U.S. treatment centers, from single-site practices to multi-state enterprise groups. The company continues to embed AI-driven workflows to simplify clinical documentation and automate revenue cycle tasks. Proceeds from its latest funding will fuel product development, expanded customer support, and enterprise-grade features. While specific revenue or user figures were not disclosed, the firm positions itself as a growth-stage software provider in a traditionally fragmented market.
- Digitail
Led · Series B · Nov 2025
Founded in 2018 by Sebastian Gabor and Ruxandra Pui, Digitail offers an all-in-one, AI-native operating system that unifies scheduling, medical records, invoicing, inventory management, client communication, wellness plans, and a pet-parent app. Its 15+ AI workflows—such as intelligent patient intake and AI-driven SOAP note dictation—aim to cut administrative work while improving accuracy and quality of care. Over the last year the company has more than doubled its customer base and now serves 10,000 veterinarians and 3 million pet parents across independent clinics, multi-location practices, and mobile vets. Clinics using Digitail report saving 50+ hours of administrative work each month and the ability to see up to twice as many patients per day. The platform integrates with 30+ third-party tools, reinforcing its position as a unified clinic operating system. With the latest Series B financing, Digitail’s total funding exceeds $37 million, giving it resources to expand globally and advance its AI capabilities.
- Magma Math
Led · Equity · Oct 2025
Founded in Sweden in 2015, Magma Math combines research-backed pedagogy with intelligent technology to support K-12 mathematics instruction. The cloud-based platform makes student reasoning visible, enabling teachers to run formative assessments, guide class discussions, and personalize learning. Magma Math claims that classrooms using its product have achieved up to a 400% improvement in math outcomes versus non-users. Now operating from offices in Sweden, the United States, and the United Kingdom, the company is positioning itself as a global leader in AI-driven education technology. Recent backing from the Gates Foundation is helping Magma Math build teacher-focused AI tools that recognize student thinking and surface actionable insights. With fresh capital, the team plans to expand headcount, enter additional international markets, and deepen its AI capabilities while keeping teachers at the center of learning.
- Barti Software
Led · Series A · Aug 2025
Barti provides an AI-powered electronic health record (EHR) and practice management system built for optometrists, opticians, and ophthalmologists. Its end-to-end operating system unifies clinical, operational, and financial workflows—including charting, scheduling, billing, phones, payments, and marketing—into a single platform to replace disconnected legacy tools. Product highlights include an AI Scribe tailored for eye care, a native phone/VoIP system, website management, and AI agents designed to automate routine administrative work. The company says its AI agents are approaching capabilities to handle calls, optimize inventory and pricing, scrub and submit insurance claims, and analyze clinical images, with a goal to automate 80%+ of routine admin tasks. Barti has onboarded more than 200 practices in the past three years and is the first company invested in by AOAExcel, the for‑profit subsidiary of the American Optometric Association. Headquartered in San Francisco, Barti plans to accelerate its AI roadmap, expand into ophthalmology, grow its team, and scale go-to-market efforts.